We provide full patent protection for the mRNA medicines that we design for you. Our services include consulting, IP Licensing, and mRNA/ SamRNA design, and aim to expand to manufacture in the future.
Consulting
mRNA Design
IP Liscensing
About US
The Company
The privately owned company is registered as SamRNA Co., Ltd. We own the patents of self-amplifying mRNA technology and aim to support mRNA medicine and its applications.
01/ Our Goal
Facilitate and support the development of self-amplifying mRNA (SamRNA) technology.
02/ Technology
Our R&D team has identified and further modified the coronaviral and HCV RdRp-binding sites, of which the related patents have been filed for securing IP protection and supporting the development of SamRNA technologies.
03/ Topnotch Experts
Dr. Shi-Lung Lin was the first researcher who developed novel PCR-IVT method for generating full-length mRNAs in 1999 and invented another PCR method to amplify RNA virus genomes. His recent work is extending to SamRNA technology and its applications.